XML 25 R15.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Note 8 - Concentrations of Credit Risk | 9 Months Ended
--- | ---
Jul. 31, 2022
Notes to Financial Statements |
Concentration Risk Disclosure [Text Block] | Note 8 – Concentrations of credit risk Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. We maintain our cash and cash equivalents with high-credit quality financial institutions. At July 31, 2022, we had cash and cash equivalent balances in excess of federally insured limits in the amount of approximately $3.8 million. Sales from each customer that were 10% or greater of net sales were as follows:
|  | Three Months Ended July 31, |  |  | Nine Months Ended July 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Wireless provider |  |  | 16% |  |  |  | 21% |  |  |  | 23% |  |  |  | 11% |
Distributor A |  |  | * |  |  |  | 10% |  |  |  | * |  |  |  | 12% |
Distributor B |  |  | * |  |  |  | 10% |  |  |  | * |  |  |  | 11% |
* Less than 10%
For the nine months ended July 31, 2022, one wireless carrier customer accounted for 23% of net sales and 19% of total net accounts receivable balance. Two customers, both distributors, accounted for approximately 12% and 11% of net sales and had accounts receivable balances that accounted for 8% and 8%, respectively, of the total net accounts receivable balance for the nine months ended July 31, 2021. Although these customers have been on-going major customers of the Company, the written agreements with these customers do not have any minimum purchase obligations and they could stop buying our products at any time and for any reason. A reduction, delay or cancellation of orders from these customers or the loss of these customers could significantly reduce our future revenues and profits.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -URI https://asc.fasb.org/topic&trid=2134479 + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration